rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2001-3-19
|
pubmed:abstractText |
The authors undertook a prospective evaluation of the clinical value of 2-fluoro [18-]-2-deoxyglucose positron emission tomography (FDG-PET) in the detection and staging of malignant lymphoma compared with computed tomography (CT) and bone marrow biopsy (BMB).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0008-543X
|
pubmed:author |
pubmed-author:AltehoeferCC,
pubmed-author:BuchmannII,
pubmed-author:BunjesDD,
pubmed-author:ElsnerKK,
pubmed-author:FinkeJJ,
pubmed-author:GlattingGG,
pubmed-author:GuhlmannC ACA,
pubmed-author:KotzerkeJJ,
pubmed-author:MosesDD,
pubmed-author:ReinhardtMM,
pubmed-author:ReskeS NSN,
pubmed-author:SchirrmeisterHH
|
pubmed:copyrightInfo |
Copyright 2001 American Cancer Society.
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
91
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
889-99
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11251940-Adolescent,
pubmed-meshheading:11251940-Adult,
pubmed-meshheading:11251940-Aged,
pubmed-meshheading:11251940-Antimetabolites,
pubmed-meshheading:11251940-Biopsy,
pubmed-meshheading:11251940-Bone Marrow,
pubmed-meshheading:11251940-Deoxyglucose,
pubmed-meshheading:11251940-Female,
pubmed-meshheading:11251940-Fluorine Radioisotopes,
pubmed-meshheading:11251940-Hodgkin Disease,
pubmed-meshheading:11251940-Humans,
pubmed-meshheading:11251940-Lymphoma, Non-Hodgkin,
pubmed-meshheading:11251940-Male,
pubmed-meshheading:11251940-Middle Aged,
pubmed-meshheading:11251940-Neoplasm Invasiveness,
pubmed-meshheading:11251940-Neoplasm Staging,
pubmed-meshheading:11251940-Tomography, Emission-Computed,
pubmed-meshheading:11251940-Tomography, X-Ray Computed
|
pubmed:year |
2001
|
pubmed:articleTitle |
2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
|
pubmed:affiliation |
Department of Nuclear Medicine, Ulm University Hospital, Ulm, Germany. inga.buchmann@medizin.uni-ulm.de
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|